Retatrutide Nasal
For Research Use Only
Nasal
The newest compound in the GLP-1 family, retatrutide adds a third mechanism — glucagon receptor activation — on top of the GLP-1 and GIP pathways used by semaglutide and tirzepatide. That third pathway is the differentiator: instead of only reducing appetite, it also raises the body's resting energy expenditure and fat-burning rate. Early trial data shows this triple-action approach outperforming earlier-generation compounds, though as the newest of the three, it has the least long-term human data behind it. Commonly used for: the most aggressive fat-loss and metabolic-rate protocols on the menu
Size: 20mg
$600.00
Out of stockThis size is out of stock. Choose another size, or request it below.
Checkout opens once payment is connected.
Certificates of analysis
No certificate has been published for this product yet.
This product is not for human or animal consumption. Misuse of this product is illegal.